ESC Professional Premium Access

Pharmacological and metabolic impact on ventricular arrhythmias

Event: ESC Congress 2022
Topic: Drug Treatment of Ventricular Arrhythmias
Session type: Moderated ePosters
Date: 29 August 2022
Time: 17:15 - 17:45

Congress Session

4 presentations in this session

Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs

Speaker: Professor G. Frommeyer (Munster, DE)
Thumbnail

Amiodarone and ventricular fibrillation amplitude of spectral area in patients with out-of-hospital cardiac arrest. Is there an effect?

Speaker: Doctor F. Gentile (Pavia, IT)
Thumbnail

Clinical features of drug-induced long QT syndrome in a large prospective cohort

Speaker: Doctor J. Guerra Ramos (Barcelona, ES)
Thumbnail

Bariatric surgery reverses ventricular repolarisation heterogeneity in obesity: mechanistic insights into fat-related arrhythmic risk

Speaker: Ms N. Herath (GB)
Thumbnail

4 speakers from this session

Professor Gerrit Frommeyer

University Hospital of Munster, Munster (Germany)
0 follower

Doctor Francesca Romana Gentile

I.R.C.C.S. San Matteo Polyclinic, Pavia (Italy)
0 follower

Doctor Jose M Guerra Ramos

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)
3 presentations
0 follower

Ms Nihara Herath

, (United Kingdom of Great Britain & Northern Ireland)
0 follower

This platform is supported by

logo Novo Nordisk